Viewing nowCombinationEmpaglom 12.5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 202501916 · Approved 2025.07.25 · Insurance code 645307240
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help control blood sugar in adults with type 2 diabetes who are appropriate for combination therapy with Empagliflozin and Metformin. It is effective for patients whose blood sugar is not adequately controlled, particularly at risk for cardiovascular events in patients with established cardiovascular disease. This medication helps improve blood sugar and assists in managing type 2 diabetes.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin as they were previously taking. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, sections 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you forget to take this medicine, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, section 3. Patients Requiring Caution, subsection 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, section 2. Patients Who Must Not Use This Medicine, subsection 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication helps control blood sugar levels. However, there are several precautions that must be adhered to when taking this medication. First, this medication can cause a dangerous condition called severe lactic acidosis, and should not be used in cases of impaired kidney function, severe infection, dehydration, etc. Also, when used together with insulin or other diabetes medications, there is a risk of hypoglycemia, so caution is advised. This medication should not be used in patients with moderate to severe renal impairment, acute heart problems, severe liver dysfunction, pregnant or breastfeeding women, and those with certain acute illnesses. During the course of treatment, regular monitoring of kidney function should be conducted to ensure there are no abnormalities, and if dehydration, vomiting, diarrhea, etc. occur, a physician should be consulted immediately. This medication can cause urinary tract infections or genital infections, so if symptoms of infection emerge, prompt treatment is necessary. Additionally, this medication may cause fluid volume reduction, thus older adults or patients with low blood pressure should take special care. Vitamin B12 levels may decrease, so if taken long-term, it is advisable to verify through blood tests. Excessive alcohol consumption can increase the risk of adverse effects from this medication, thus alcohol intake should be avoided during treatment. When undergoing surgery or radiological examinations with contrast media, this medication should be temporarily discontinued and resumed only after kidney function is confirmed as normal. This medication is not recommended for children, and dosage adjustments and monitoring of kidney function are necessary for older adults. Finally, while taking this medication, if any unusual symptoms such as fever, pain or swelling around the genital area, skin rash, severe fatigue, etc. occur, immediate consultation with healthcare personnel is required.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent contact with air or moisture, and is best kept at room temperature between 1 and 30 degrees Celsius. This way of storage helps maintain the effectiveness of the medication.
White, oval, biconvex, film-coated tablet with a pink tinge
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.